A novel inhibitor for MEK1 kinase- MST found it!

End of last year, Sanofi and NanoTemper Technologies released a publication describing an automated MicroScale Thermophoresis (MST) affinity screening approach to identify fragments active against the cancer target MEK1 kinase.

Previous Video
NanoTemper Technologies at PEGS Europe
NanoTemper Technologies at PEGS Europe

NanoTemper Technologies goes PEGS Europe…not just with a booth, but with the first ever live instrument dem...

Up next
Handling for Prometheus NT.48
Handling for Prometheus NT.48

NanoTemper Technologies offers nanoDSF technology with the Prometheus NT.48 instrument. nanoDSF is the meth...